温伟波教授从脾论治高脂血症经验浅析
|
摘要
通过医案的系统梳理,总结了温伟波教授从"脾"论治高脂血症的治疗方法和临床经验。导师温伟波教授认为高脂血症的基本病机是脾失健运,痰、湿、瘀相互搏结,阻滞经络是高脂血症发生发展的主要病机,临床以健脾祛湿、化痰活血为治疗大法,"调脂化浊汤"为温伟波教授从"脾"论治高脂血症的代表方。
Through the systematic review of medical records,summarizes Professor WEN Weibo's treatment methods and clinical experience in treating hyperlipidemia from "spleen". Professor WEN Weibo believes that the basic pathogenesis of hyperlipidemia is the disfunction of spleen in transport,the combination of wetness,phlegm and blood stasis,and then blocking meridians. The therapy is invigorating spleen to eliminate dampness,activating blood circulation and resolving phlegm. The prescription of "Tiaozhi Huazhuo" is the representative formula of Professor WEN Weibo's treatment to treat hyperlipidemia from the "spleen".
Through the systematic review of medical records,summarizes Professor WEN Weibo's treatment methods and clinical experience in treating hyperlipidemia from "spleen". Professor WEN Weibo believes that the basic pathogenesis of hyperlipidemia is the disfunction of spleen in transport,the combination of wetness,phlegm and blood stasis,and then blocking meridians. The therapy is invigorating spleen to eliminate dampness,activating blood circulation and resolving phlegm. The prescription of "Tiaozhi Huazhuo" is the representative formula of Professor WEN Weibo's treatment to treat hyperlipidemia from the "spleen".
引文
[1] 国家卫生和计划生育委员会疾病预防控制局.中国居民营养与慢性病状况报告[S].北京:人民卫生出版社,2015
[2] Moran A,Gu D,Zhao D,et al.Future cardiovascular disease in china:markov model and risk factor scenario projections from the coronary heart disease policy model-china.Circ Cardiovasc Qual Outcomes,2010,3:243～252
[3] 陈家伦,宁光,潘长玉,等.临床内分泌学[M].上海:上海科学技术出版社,2017
[4] 陈娟,邓军,张宇燕,等.丹参素对高脂血症大鼠脂代谢调节机制研究[J].中国中药杂志,2015,40(2):313～317
[5] Wang W,Ma B,Hu X,et al.The Effect of Tanshinone ⅡA and simvastatin treating the legs atheromatosis[J].Chinese Journal of Arteriosclerosis,2010,18(11):897～899
[6] 王颖,郭兰萍,黄璐琦,等.姜黄、莪术、郁金的化学成分与药理作用研究进展[J].中国药房,2013,35(24):3338～3341
[7] 韩冬.黄芪甲苷对实验性糖尿病大鼠降糖、调脂和抗氧化作用的研究[J].现代中西医结合杂志,2016,25(4):360～364
[8] Y F Wang,X F Yang,B Cheng,et al.Protective effect of As-tragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha[J].Phytother Res,2010,24(3):393
[9] Wu CH,Yang MY,Chan KC,et al.Improvement in high-fat diet-induced obesity and body fat accumulation by a Nelumbo nucifera leaf flavonoid-rich extract in mice[J].J Agr Food Chem,2010,58(11):7075～7081
[10] 赵水平.降血脂药物国外研发的发现[J].中国医药技术,2012,6(2):54～56
[11] 夏伦祝,徐先祥,张睿.太子参多糖对糖尿病大鼠糖、脂代谢的影响[J].中国药业,2009,18(9):17
[12] 彭敏,顾施健,姜淋洁,等.白术提取物降血脂作用的有效部位研究[J].时珍国医国药,2011,22(10):2363～2365
[13] 唐琪晶,陈素红,潘丹丹,等.白术精提物对代谢性高脂血症大鼠的药效及机制研究[J].中国中药杂志,2015,09(40):1803～1807
[14] 毛跟年,张诗韵,付超,等.茯苓皮总三萜的降血脂活性研究[J].陕西科技大学学报,2015,33(3):131～134
[15] 刘祥兰,徐颖,张钰泉,等.猪苓多糖降血脂抗大鼠酒精性脂肪肝的药理实验研究[J].中成药,2013,35(8):1760～1764
[16] 赵秀玲.陈皮生理活性成分研究进展[J].食品工业科技,2013,34(12):376～381
[17] 魏淑红,彭正松.半夏类药材研究概况[J].中药材,2003,26(11)828～832
[18] 瞿璐王,涛董,勇喆,等.菊花化学成分与药理作用的研究进展[J].2015,38(1):98～104
[19] 李海华,青梅,于娟,等.甘草的研究进展[J].内蒙古医科大学学报,2015,37(2):197～204
[2] Moran A,Gu D,Zhao D,et al.Future cardiovascular disease in china:markov model and risk factor scenario projections from the coronary heart disease policy model-china.Circ Cardiovasc Qual Outcomes,2010,3:243～252
[3] 陈家伦,宁光,潘长玉,等.临床内分泌学[M].上海:上海科学技术出版社,2017
[4] 陈娟,邓军,张宇燕,等.丹参素对高脂血症大鼠脂代谢调节机制研究[J].中国中药杂志,2015,40(2):313～317
[5] Wang W,Ma B,Hu X,et al.The Effect of Tanshinone ⅡA and simvastatin treating the legs atheromatosis[J].Chinese Journal of Arteriosclerosis,2010,18(11):897～899
[6] 王颖,郭兰萍,黄璐琦,等.姜黄、莪术、郁金的化学成分与药理作用研究进展[J].中国药房,2013,35(24):3338～3341
[7] 韩冬.黄芪甲苷对实验性糖尿病大鼠降糖、调脂和抗氧化作用的研究[J].现代中西医结合杂志,2016,25(4):360～364
[8] Y F Wang,X F Yang,B Cheng,et al.Protective effect of As-tragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha[J].Phytother Res,2010,24(3):393
[9] Wu CH,Yang MY,Chan KC,et al.Improvement in high-fat diet-induced obesity and body fat accumulation by a Nelumbo nucifera leaf flavonoid-rich extract in mice[J].J Agr Food Chem,2010,58(11):7075～7081
[10] 赵水平.降血脂药物国外研发的发现[J].中国医药技术,2012,6(2):54～56
[11] 夏伦祝,徐先祥,张睿.太子参多糖对糖尿病大鼠糖、脂代谢的影响[J].中国药业,2009,18(9):17
[12] 彭敏,顾施健,姜淋洁,等.白术提取物降血脂作用的有效部位研究[J].时珍国医国药,2011,22(10):2363～2365
[13] 唐琪晶,陈素红,潘丹丹,等.白术精提物对代谢性高脂血症大鼠的药效及机制研究[J].中国中药杂志,2015,09(40):1803～1807
[14] 毛跟年,张诗韵,付超,等.茯苓皮总三萜的降血脂活性研究[J].陕西科技大学学报,2015,33(3):131～134
[15] 刘祥兰,徐颖,张钰泉,等.猪苓多糖降血脂抗大鼠酒精性脂肪肝的药理实验研究[J].中成药,2013,35(8):1760～1764
[16] 赵秀玲.陈皮生理活性成分研究进展[J].食品工业科技,2013,34(12):376～381
[17] 魏淑红,彭正松.半夏类药材研究概况[J].中药材,2003,26(11)828～832
[18] 瞿璐王,涛董,勇喆,等.菊花化学成分与药理作用的研究进展[J].2015,38(1):98～104
[19] 李海华,青梅,于娟,等.甘草的研究进展[J].内蒙古医科大学学报,2015,37(2):197～204